Multidrug-resistant strains of tubercle bacilli isolated from pulmonary tuberculosis retreatment patients in Sierra Leone, West Africa. 1993

V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
April 2022, The Lancet. Global health,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
March 2024, Microbiology spectrum,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
June 1991, Headache,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
October 1964, Zeitschrift fur Tuberkulose und Erkrankungen der Thoraxorgane,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
December 1962, Tubercle,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
November 1996, The British journal of ophthalmology,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
April 1974, The Japanese journal of antibiotics,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
June 1986, Tubercle,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
October 1999, International journal of antimicrobial agents,
V Sticht-Groh, and S Rüsch-Gerdes, and F Boillot, and M Remillieux
January 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!